Argentina
Tuberculosis profile
Population  2012 41 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.55 (0.53–0.58) 1.3 (1.3–1.4)
Mortality (HIV+TB only) 0.047 (0.041–0.06) 0.11 (0.1–0.15)
Prevalence  (includes HIV+TB) 15 (6.5–27) 36 (16–65)
Incidence  (includes HIV+TB) 10 (8.6–12) 25 (21–30)
Incidence (HIV+TB only) 0.27 (0.22–0.32) 0.66 (0.55–0.78)
Case detection, all forms (%) 84 (71–100)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 4 661 (55) Relapse 322 (28)
Smear-negative 1 327 (16) Treatment after failure 8 (<1)
Smear-unknown / not done 1 014 (12) Treatment after default 343 (29)
Extrapulmonary 1 291 (15) Other 497 (42)
Other 143 (2)      
Total new 8 436   Total retreatment 1 170  
           
Other (history unknown)          
Total new and relapse 8 758   Total cases notified 9 606  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 0.7 0.9 0.8
Age < 15 126 619 86
Laboratories 2012
Smear (per 100 000 population) 1.7
Culture (per 5 million population) 12.5
Drug susceptibility testing (per 5 million population) 1.9
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 52   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 44  
Retreatment 41  
TB/HIV 2012 Number (%)
TB patients with known HIV status 1 434 (15)
HIV-positive TB patients 685 (48)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.2 (1.2–3.6) 15 (9.8–23)
MDR-TB cases among notified pulmonary
TB cases
160 (88–260) 180 (110–260)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB      
Laboratory-confirmed MDR-TB cases 13 26 63
Patients started on MDR-TB treatment     63
Financing TB control 2013
National TB programme budget (US$ millions) 3.7
% Funded domestically 100%
% Funded internationally  
% Unfunded 0%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-19 Data: www.who.int/tb/data